Marizomib Central Nervous System (CNS)

Clinical trial NCT05050305 · WITHDRAWN

Trial details

NCT number: NCT05050305
Sponsor: Dana-Farber Cancer Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Multiple Myeloma in Relapse Multiple Myeloma, Refractory

Start date: 2024-03-01
Primary completion: 2025-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.